2015
DOI: 10.1055/s-0034-1393251
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the clinical impact of endoscopic ultrasound-guided choledochoduodenostomy and hepaticogastrostomy for bile duct obstruction with duodenal obstruction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
52
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 36 publications
(56 citation statements)
references
References 0 publications
4
52
0
Order By: Relevance
“…The present study is the largest series to date, involving 109 patients with DS, not including endoscopic ultrasound (EUS)‐guided biliary drainage (EUS‐BD). The technical success rate of DS ranges from 82% to 100% . Our identified rate (99.1%) is similar to this, and clinical success was achieved in 81.7%.…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…The present study is the largest series to date, involving 109 patients with DS, not including endoscopic ultrasound (EUS)‐guided biliary drainage (EUS‐BD). The technical success rate of DS ranges from 82% to 100% . Our identified rate (99.1%) is similar to this, and clinical success was achieved in 81.7%.…”
Section: Discussionsupporting
confidence: 81%
“…Endoscopic stenting using self‐expandable metal stents (SEMSs) is an effective and minimally invasive treatment in cases of duodenal obstruction and for palliation of biliary obstruction . In recent years, biliary and duodenal stenting (DS; double stenting) has been used to treat combined biliary and duodenal obstructions . An uncovered SEMS (U‐SEMS) was used as the type of duodenal SEMS in most previous DS cases.…”
Section: Introductionmentioning
confidence: 99%
“…In cases with a biliary stent in situ , duodenal tumor invasion can be a risk factor for biliary stent dysfunction as a result of enhanced duodenobiliary reflux . Given the feasibility of endoscopic ultrasound‐guided transmural biliary drainage including choledochoduodenostomy and hepaticogastrostomy in patients with an indwelling duodenal SEMS, concern with biliary obstruction might be minimal in current clinical practice, but attention should be paid to avoid SEMS‐related pancreatitis …”
Section: Discussionmentioning
confidence: 99%
“… reported a mean stent patency of 133 days: 152 days for CDS and 132 days for HGS. However, EUS‐BD resulted in a longer patency than did EBD in cases with duodenal stenosis or an indwelling duodenal stent , with EUS‐HGS showing a longer patency than that of EUS‐CDS .…”
Section: Questions and Clinical Questions Of The Guidelinesmentioning
confidence: 88%